Dr. Ronnie Wei is Head of Biologics Discovery and Development at ModeX, responsible for developing novel multispecific therapeutics for immune-oncology and infectious disease indications. Prior to joining ModeX, she was Director for Scientific Innovation at Sanofi from 2018 to 2020. Ronnie managed the operations of the Chief Scientific Office and facilitated the implementation of strategies for R&D by driving innovation through Sanofi’s Scientific Intelligence Network. Ronnie also served as a scientific advisor for the Sanofi Breakthrough Laboratory. Prior to this role, she was Director of Protein Engineering at Dragonfly Therapeutics where she designed and established the multispecific NK cell engaging platform which has since seen its first molecule in patients.
Dr. Wei has a demonstrated track record of delivering high quality and innovative biologics designs that have reached clinical development. In her work Ronnie regularly surveys the competitive intelligence landscape and patent space on cutting edge therapeutic concepts, fostering deep ties with partners in the biopharma and academia investment ecosystem. Her research has led to 22 publications including manuscripts in Science, Cell, Nature Journals and PNAS as well as over 20 patents filed and granted.
Ronnie received her B.Sc. from Tsinghua University in Beijing, China, a Ph.D. at Indiana University, and an MBA from Boston College. She was a postdoctoral research fellow with Dr. Stephen Harrison at the Harvard Medical School and Howard Hughes Medical Institute.